About your Search

20100101
20100131
Search Results 0 to 10 of about 11 (some duplicates have been removed)
people are taking issue with the large amount of money the united states hands out to other countries. one of the largest mortgage lenders is trying to help homeowners face foreclosure. that's coming up next. ♪ ♪ ♪ [male announcer] to the men and women of the united states armed forces, the uso delivers the joys and comforts of home. even out here. find out how you can help at uso.org the uso. until every one comes home. ♪ fallinbehind on their mortgages, no one profit groups are teaming up to save homeowners from foreclosure. joining us now to talk about this is dwight robinson, a, sr. vice president of community relations at freddie mac. your company is joining 13 no one profit groups to help struggling homeowners. how do you plan to help them? >> we're really excited about our initiative working with non-profit groups for home buyers who may have become discouraged, disillusioned or frustrated with the process of trying to save their homes and to avoid foreclosure. we've teamed up with the non-profits to provide phone counseling that will put people in position to enhance a
to describe it. you can say turbulent or chaotic. it is a bloodbath of a year. in the united states, sales will be on the lowest level on a per capita basis since the late 950s. >> tell us some factors that contributed to that year in autos. >> it has been building since 2007 with the collapse in the housing market then we had, in the auto industry, i don't think people realized, the recession didn't start with lehman brothers, it happened before that with collapsing consumer confidence with housing going down in '07 in ski auto marks like california and florida. so even throughout '08 you had gas prices just killing detroit in particular which is much more relying on the light truck segment. then lehman happened and all that just just cascaded into 20d let to massive collapses, each month the sales numbers were horrendous and we're down year to date 24% and the only bright idea was cash for clunkers. >> was that program a big success? can you call cash for clunkers a successful program? >> yes, because it wasn't too long to the point where it is going to pull a ton of 2010 deman in 2009.
change your life. watch the "700 club". ♪ ♪ ♪ [male announcer] to the men and women of the united states armed forces, the uso delivers the joys and comforts of home. even out here. find out how you can help at uso.org the uso. until every one comes home. ♪ the president's state of the union address, and the u.s. senate has just a few more days to vote on federal reserve chairman ben bernanke's nomination for a second term. bob chirinko is here with his in sight. welcome to the show, bob. >> thank you. >> how do you think the state of the union address could take shape? >> i believe he'll talk about concerns facing the electorate. government is too large, bank bonuses are too large. >> is mr. obama losing credibility with the american people? >> i think very much so. there's a great deal of concern from different quarters about government spending. we're all concerned about unemployment, and certainly a sub set of people are concerned about bank bonuses, but not necessarily everybody. >> what do investors want to hear from the president? >> all of those things that insure that inflatio
reform and how it affects what you pay for drugs. health care spending in the united states it reached $2.3 trillion in 2008. that's an average of more than $7,600 per person. according to the department of health and human services. it is an increase of more than 4% from 2007. as lawmakers negotiate on the two different versions of health care legislation, we continue our two-part series and this time we take a closer look at how the proposed legislation impacts the pharmaceutical industry and how much we pay for drugs. earlier, we spoke with damien conover, independent analyst at morningstar. so how would you describe the impact of this health care reform on big pharma? is it going to be negative or positive, if it indeed goes through? >> right, what we're seeing is likely the reform proposal coming out of the senate and that particular proposal looks like it is going to be slightly beneficial for the pharmaceutical companies, but i think more perform that it looks like it is more likely neutral than anything. >> big pharma, we know, is going to be facing a lot of industry fees under th
involving united states and europe. we have intel settling with competitors, appealing the fine in europe, fighting off both state antitrust officials in new york and other states that may join and now the ftc with an administration complaint. >> so administration complaint means it will not be going to a jury, it is just decided within the system, correct? >> first step is, ftc has brought a case under section five of the federal trade commission act alleging allegint intel does is an unfair method of competition it goes an administration law judge and either side can appeal at the federal level. >> looking ahead to between is there a likelihood this will be settled or this case will drag throughout the year? >> it is hard to say, the case has just started but intel looks like they're trying to resolve all of their legal issues by settling with competitors, depends if they can settle with the european union. if they can, they should be able to settle with the federal trade commission. they're not seeking a fine, it is not permitted under the ftc act, there is no jail time, it is not a cr
] to the men and women of the united states armed forces, the uso delivers the joys and comforts of home. even out here. find out how you can help at uso.org statement, no surprises there, but we're still going to break it down with dan cook from i.g. markets. he joins us now. welcome to the show, dan. of course, interest rates are kept the same, close to zero. the committee sees this usual phrase, exceptal levels raised for an extended period. the feds are refusing to give any hint about when they're going to raise interest rates. is that the right approach. >> the data has been positive, but not overwhelmingly so. they have a lot of other tools they can utilize other than interest rates for a while. >> there is one that dissentedsd from that phrase keeping interest rates low for a period of time. >> it is a phrase. i think we'll see more in the meeting minutes. it seems like we're going to start to see more of that. as we start to see signs of the market improving, there will probably be a few dissenters. >> okay. we could see a further battle down the road about the question about raising r
to be the leader of the country. on an international scale, being the face of the united states, couldn't be more proud of him. >> i'd give him an a, also. people have to give him some time. one year can't fix all the problems that this country has accumulated in the last eight years. >> i would give him an a. congress i would give a little lower to. >> what grade would you give congress. >> maybe a c, business at usual. >> our poll was unscientific. a recent national poll found the reviews are mixed with half saying the president's first year was a failure, and an equal percentage of people calling the first year a success. >> companies are free to spend as much as they want to support or oppose politicians running for federal public offices, as long as they do not donate to candidates directly. on thursday, the supreme court in a 5-4 decision struck down part of the mccain campaign finance law. the court ruled the corporations have the same free speech right as individuals, which means the government cannot stop companies from buying bill boards or commercials to support certain candidates. the
. in the united states we spend almost double on health care as other industrialized nations as a percentage of gdp and that sparked the health care reform debate in the begin but as we've seen it take shape we don't see what is enacted to lower the spending for health care as a nation as a whole. >> this debate is not over yet by a long shot because we have several more months possibly of debate as lawmakers try to finalize the ball. thank you very much, damien conover with morningstar. thank you. >> thank you. >> a look at how the upcoming consumer electronics show could affect the technology sector. that's next, "i was afraid of the public. i was afraid that everybody i stopped was gonna shoot me." "one night right at dusk i stopped this vehicle for speeding and the guy jumped out of his car and i saw that he had a gun in his hand i drew my revolver and focussed on his hands and it wasn't a gun it was his billfold." "i drove straight to my sergeant's house and told him, i'm done.'" how steve watt fought his way back from overwhelming fear. on the 700 clñc after this "in the know" message
in the united states. and it also raises the issue of yes, here in america we do pay more for the same drug than, say, europeans pay. they definitely have a different system, but i was talking to my brother who actually works in the pharmaceutical industry, and he says that drug companies are going to charge whatever they want, whatever the market will bear. >> and it's supply and demand in the health care industry just like it is everywhere else. it's interesting that prices in health care are a little bit more owe make. you often don't know what you're paying for a certain procedure until you get that bill after the insurance covers it and all that nonsense. >> exactly. even month to month prescription prices with vary wildly. >> very inconsistent. moving on to how much politicians are making in their paycheck, we have a viewer concerned about that. >> yes, the politicians do make more and they do their job, but they don't do it efficiently. they want to tax us, let them tax themselves. let them give up all those perks. >> i think it's interesting that it's the voters that actually decide who
Search Results 0 to 10 of about 11 (some duplicates have been removed)

Terms of Use (10 Mar 2001)